The fact that BSV is one of the very few Indian companies expected to obtain
UK-MCA (expected by March 2004) approved plant for the manufacture of injectables speaks of the Company's strengths in the formulation development, project implementation and in attracting and tying up with leading pharmaceutical companies of the world for distribution in the regulated markets.

BSV has a formidable product pipeline in various stages of development. Since the Company has quite a few potential blockbuster products in its portfolio, it is now looking for alliances with potential partners with proven strengths in the marketing and distribution of similar products. BSV firmly believes that by following the model business alliances and strategic partnerships, it can significantly reduce the time required to commercialize these products globally.